Iguana Healthcare Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Iguana Healthcare Management’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-65,000	Closed	-$912K	–	81
2015 Q3	$912K	Buy	+65,000	New	+$1.21M	0.36%	62
2014 Q3	–	Sell	-150,000	Closed	-$1.64M	–	78
2014 Q2	$1.64M	Buy	+150,000	New	+$1.34M	0.77%	46
2014 Q1	–	Sell	-100,000	Closed	-$714K	–	93
2013 Q4	$714K	Buy	+100,000	New	+$699K	0.41%	59

Other funds holding SUPN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

RCAMU

Rothschild & Co Asset Management US Stamford, Connecticut $6.58B AUM 4.5% 1-Year Est. Return

Iguana Healthcare Management's SUPN Position: Q1 2018 in Review

Iguana Healthcare Management sold out of Supernus Pharmaceuticals (SUPN) in Q1 2018, closing a stake of 50,000 shares — an estimated $1.99M sold.

Iguana Healthcare Management first reported a position in SUPN in Q1 2014 and held it in 14 quarters. The position peaked at $7.42M in Q3 2016. 312 funds tracked by Wall St. Rank hold SUPN as of Q1 2018.

Iguana Healthcare Management reported no remaining Supernus Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
Iguana Healthcare Management sold 50,000 Supernus Pharmaceuticals shares in Q1 2018, an estimated $1.99M.
Iguana Healthcare Management first reported a position in Supernus Pharmaceuticals in Q1 2014 and held it in 14 quarters.
Iguana Healthcare Management's Supernus Pharmaceuticals position peaked at $7.42M in Q3 2016.
312 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2018.

Based on Iguana Healthcare Management's 13F filing for Q1 2018, filed 15 May 2018.